## Clinical Presentation **Key Point:** Trigeminal neuralgia (TN) is a disorder of the trigeminal nerve (CN V) characterized by sudden, severe, unilateral, lancinating pain in the distribution of one or more divisions of the trigeminal nerve. ## Diagnostic Criteria for Trigeminal Neuralgia | Feature | Trigeminal Neuralgia | Glossopharyngeal Neuralgia | Post-herpetic Neuralgia | | --- | --- | --- | --- | | **Distribution** | V1, V2, or V3 (CN V) | Pharynx, soft palate, ear (CN IX) | Dermatomal, follows vesicular rash | | **Pain character** | Sharp, lancinating, electric | Sharp, throat/ear pain | Burning, constant, dull | | **Trigger factors** | Touch, chewing, cold wind, talking | Swallowing, coughing, yawning | Spontaneous; minimal trigger | | **Duration** | Seconds to 2 minutes | Seconds to 2 minutes | Hours to continuous | | **Exam findings** | Normal (idiopathic) | Normal | Sensory loss in dermatomal pattern | | **MRI** | Normal or neurovascular compression | Normal | Normal | ## Why This Patient Has Trigeminal Neuralgia 1. **Distribution:** Pain is in the right V2 and V3 (cheek and upper jaw) — classic trigeminal distribution. 2. **Trigger factors:** Chewing, touch, and cold wind are pathognomonic triggers for TN. 3. **Duration:** 10–30 seconds per episode fits the brief, paroxysmal pattern of TN. 4. **Normal exam:** Idiopathic TN has a completely normal neurological examination. 5. **Normal imaging:** MRI is normal, ruling out secondary causes (tumour, demyelination). **High-Yield:** Idiopathic trigeminal neuralgia accounts for ~90% of cases; the remaining 10% are secondary to MS, tumour, or vascular compression (symptomatic TN). ## Pathophysiology **Clinical Pearl:** The leading hypothesis is **ephaptic transmission** — abnormal cross-talk between demyelinated A-delta fibres (carrying touch) and C fibres (carrying pain) in the trigeminal ganglion or root entry zone. A light touch stimulus is misinterpreted as severe pain. ## First-Line Management - **Carbamazepine** 100–200 mg BD (gold standard; ~70% response). - **Oxcarbazepine** 300–600 mg BD (better tolerability). - **Phenytoin** or **gabapentin** as alternatives. - **Surgical options** (if medical refractory): microvascular decompression, percutaneous balloon compression, radiofrequency ablation. **Mnemonic: TN-STAB** — **T**rigger factors, **N**ormal exam, **S**evere pain, **T**ransient (brief), **A**cute onset, **B**ilateral rare (unilateral ~95%). 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.